Both in Pharmaceuticals
Tango Therapeutics vs Organon &
Over the past year TNGX returned +171.7% and OGN returned +106.0%; their daily moves had a correlation of 0.03.
TNGX +171.7% OGN +106.0%Growth of $1, one year, split-adjusted
| Metric | TNGX | OGN |
|---|---|---|
| Price | $21.76 | $13.82 |
| Market cap | $3.67B | $3.63B |
| Today | −4.23% | −0.14% |
| 1 month | −6.4% | +0.7% |
| 6 months | −4.2% | +4.2% |
| Year to date | +145.6% | +92.7% |
| 1 year | +173.0% | +110.4% |
| Revenue growth (YoY) | −100.0% | −1.7% |
| Gross margin | — | 55.2% |
| Net margin | — | 10.4% |
| P/E (TTM) | — | 17.0× |
| Price / sales | 68.2× | 0.6× |
| Net cash | $1.01B | -$7.10B |
| Dividend yield | — | 0.58% |
| Volatility (60d) | 72.1% | 2.9% |
| Short % of float | 31.9% | 7.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).